Skip to main content
. 2021 Jul 29;21(3):273–283. doi: 10.1007/s40268-021-00357-0

Fig. 4.

Fig. 4

A Principal component analysis (PCA) to study the dynamics of 13-amino acid peptide inhibitor (13AApi) within the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein receptor-binding interface. B–E Screen plots showing percent variance explained by a PCA